Search

Paul R Michl

Examiner (ID: 9867)

Most Active Art Unit
1505
Art Unit(s)
1511, 3502, 1503, 2899, 1714, 1201, 1505, 1506, 3305, 1509
Total Applications
2093
Issued Applications
1688
Pending Applications
51
Abandoned Applications
353

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6064109 [patent_doc_number] => 20020032151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation' [patent_app_type] => new [patent_app_number] => 09/848353 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17565 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032151.pdf [firstpage_image] =>[orig_patent_app_number] => 09848353 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/848353
Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation May 3, 2001 Abandoned
Array ( [id] => 579239 [patent_doc_number] => 07158888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'Determining structures by performing comparisons between molecular replacement results for multiple different biomolecules' [patent_app_type] => utility [patent_app_number] => 09/848866 [patent_app_country] => US [patent_app_date] => 2001-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13149 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/158/07158888.pdf [firstpage_image] =>[orig_patent_app_number] => 09848866 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/848866
Determining structures by performing comparisons between molecular replacement results for multiple different biomolecules May 3, 2001 Issued
09/843824 Template associated NPY Y2-receptor agonists Apr 29, 2001 Abandoned
Array ( [id] => 1140785 [patent_doc_number] => 06777176 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-17 [patent_title] => 'Target system' [patent_app_type] => B1 [patent_app_number] => 09/845225 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10258 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/777/06777176.pdf [firstpage_image] =>[orig_patent_app_number] => 09845225 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/845225
Target system Apr 29, 2001 Issued
Array ( [id] => 6408060 [patent_doc_number] => 20020037851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Human semaphorin L (H-SemaL) and corresponding semaphorins in other species' [patent_app_type] => new [patent_app_number] => 09/836077 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 19579 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037851.pdf [firstpage_image] =>[orig_patent_app_number] => 09836077 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/836077
Human semaphorin L (H-SemaL) and corresponding semaphorins in other species Apr 15, 2001 Abandoned
Array ( [id] => 5828641 [patent_doc_number] => 20020068366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Proteomic analysis by parallel mass spectrometry' [patent_app_type] => new [patent_app_number] => 09/835273 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10342 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068366.pdf [firstpage_image] =>[orig_patent_app_number] => 09835273 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/835273
Proteomic analysis by parallel mass spectrometry Apr 12, 2001 Abandoned
Array ( [id] => 7451689 [patent_doc_number] => 20040010134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Albumin fusion proteins' [patent_app_type] => new [patent_app_number] => 09/833245 [patent_app_country] => US [patent_app_date] => 2001-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 181278 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010134.pdf [firstpage_image] =>[orig_patent_app_number] => 09833245 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/833245
Albumin fusion proteins Apr 11, 2001 Abandoned
Array ( [id] => 6889573 [patent_doc_number] => 20010025028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Methods of inhibiting bone resorption' [patent_app_type] => new [patent_app_number] => 09/833185 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7075 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025028.pdf [firstpage_image] =>[orig_patent_app_number] => 09833185 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/833185
Methods of inhibiting bone resorption Apr 10, 2001 Abandoned
Array ( [id] => 6342496 [patent_doc_number] => 20020034802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Crystals of the alpha 1 beta 1 integrin I-domain and their use' [patent_app_type] => new [patent_app_number] => 09/826716 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10024 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034802.pdf [firstpage_image] =>[orig_patent_app_number] => 09826716 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/826716
Crystals of the alpha 1 beta 1 integrin I-domain and their use Apr 4, 2001 Abandoned
Array ( [id] => 6306052 [patent_doc_number] => 20020094540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'N-TRADD active site and uses thereof' [patent_app_type] => new [patent_app_number] => 09/821819 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 13412 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094540.pdf [firstpage_image] =>[orig_patent_app_number] => 09821819 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/821819
N-TRADD active site and uses thereof Mar 28, 2001 Abandoned
Array ( [id] => 5907947 [patent_doc_number] => 20020142952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Polynucleotides encoding novel secreted proteins' [patent_app_type] => new [patent_app_number] => 09/822830 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26633 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142952.pdf [firstpage_image] =>[orig_patent_app_number] => 09822830 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/822830
Polynucleotides encoding novel secreted proteins Mar 28, 2001 Abandoned
Array ( [id] => 899367 [patent_doc_number] => 07343246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Spatial profiling of proteins using hydrophobic moments' [patent_app_type] => utility [patent_app_number] => 09/818461 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 13 [patent_no_of_words] => 6131 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/343/07343246.pdf [firstpage_image] =>[orig_patent_app_number] => 09818461 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/818461
Spatial profiling of proteins using hydrophobic moments Mar 26, 2001 Issued
Array ( [id] => 1220415 [patent_doc_number] => 06703238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-09 [patent_title] => 'Methods for expanding antigen-specific T cells' [patent_app_type] => B2 [patent_app_number] => 09/812528 [patent_app_country] => US [patent_app_date] => 2001-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16334 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/703/06703238.pdf [firstpage_image] =>[orig_patent_app_number] => 09812528 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/812528
Methods for expanding antigen-specific T cells Mar 19, 2001 Issued
09/791884 Method of biological and medical diagnostics using immune patterns obtained with arrays of peptide probes Feb 25, 2001 Abandoned
09/700708 Method of estimating protein functions Feb 19, 2001 Abandoned
Array ( [id] => 6838753 [patent_doc_number] => 20030036093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Methods of ab initio prediction of alpha helices, beta sheets, and polypeptide tertiary structures' [patent_app_type] => new [patent_app_number] => 09/788006 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 30999 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036093.pdf [firstpage_image] =>[orig_patent_app_number] => 09788006 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/788006
Methods of ab initio prediction of helices, sheets, and polypeptide tertiary structures Feb 15, 2001 Issued
Array ( [id] => 5800860 [patent_doc_number] => 20020009454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'Composition and method for treating inflammatory diseases' [patent_app_type] => new [patent_app_number] => 09/784623 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 27800 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20020009454.pdf [firstpage_image] =>[orig_patent_app_number] => 09784623 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/784623
Composition and method for treating inflammatory diseases Feb 14, 2001 Issued
Array ( [id] => 6342555 [patent_doc_number] => 20020034808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Crystal of bacterial core RNA polymerase' [patent_app_type] => new [patent_app_number] => 09/782714 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20715 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20020034808.pdf [firstpage_image] =>[orig_patent_app_number] => 09782714 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782714
Crystal of bacterial core RNA polymerase Feb 12, 2001 Abandoned
Array ( [id] => 5873852 [patent_doc_number] => 20020048772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Protein design automation for protein libraries' [patent_app_type] => new [patent_app_number] => 09/782004 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32315 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048772.pdf [firstpage_image] =>[orig_patent_app_number] => 09782004 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782004
Protein design automation for protein libraries Feb 11, 2001 Abandoned
Array ( [id] => 1231671 [patent_doc_number] => 06693083 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Conjugates targeted to the interleukin-2 receptor' [patent_app_type] => B2 [patent_app_number] => 09/782385 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10328 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693083.pdf [firstpage_image] =>[orig_patent_app_number] => 09782385 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/782385
Conjugates targeted to the interleukin-2 receptor Feb 11, 2001 Issued
Menu